Neuroprotective Efficacy of Therapeutic Progestins: Implications for Alzheimer's Disease
CSEF · 2003 Pharmacology/ Toxicology
Overview
Objectives/Goals The objective is to determine whether progestins synergize or antagonize the protective action of estrogen on hippocampal cell viability. Methods/Materials Hippocampal neurons were treated with steroids: 17 Beta Estradiol (a form of estrogen) and Progesterone, Norethindrone Acetate and Medroxyprogesterone Acetate (which are progestins) at a concentration of 10 ng/ml to test the neuroprotective effects of Hormone Replacement Therapy on neuronal growth and survival. The toxicity for the survival and protection experiments will be induced by high concentrations of glutamate. The number of intact cells are evaluated under a microscope and analyzed with the BioQuant imaging system. Indicators of cell death and survival including LDH and Calcein AM will be measured from the medium. Flourescent intensities using these assays were measured using a microplate reader and spectrophotometer, respectively. The extensity of damaged DNA in the neurons will be measured using the TUNEL reaction mixture with a flourescent microscope. Results Results of these experiments revealed differences in cell viability using different techniques. Using the Survival Studies technique, Calcein AM and TUNEL assays with Medroxyprogesterone Acetate there was a significant potentiation of cell death induced by excitotoxic glutamate. The LDH technique further revealed there were no significant differences in cell viability between the three progestin-treated neurons. Conclusions/Discussion The data suggests that under excitotoxic conditions, certain progestins induced neuroprotection while others do not. The results have important implications for the effective design of Hormone Replacement Therapy in maintaining cognitive functions and preventing Alzheimer's Disease.
Summary statement
My research focuses on the use of Hormone Replacement Therapy, which includes estrogen and progestin, as a preventative measure against Alzheimer's Disease.
Help received
Used lab equipment under the supervision Dr. Roberta Diaz Brinton, USC.
Competition history
- CSEF 2003
Resources
Related projects
CSEF · 2007
Alloprenanolone: Neurogenic Property and Therapeutic Potential in AD Treatment
CSEF · 2015
Allopregnanolone Site of Action for Promoting Regeneration of Human Neural Stem Cells: Uncovering the Paths
ISEF · 2024
The Effect of Potential Anti-Inflammatory Sex Hormones to Model the Gender and Age Discrepancy in Alzheimer’s Disease Using C. elegans as a Model Organism for a Preventative Mechanism
ISEF · 2014
Nicotine and Genistein as Novel Therapeutic Agents for Alzheimer's Disease
ISEF · 2025
Paving the Path to the Impossible: Regenerating Neurons Using Prostaglandin E2 Regulation as a Therapeutic Strategy
CSEF · 2017
The Effects of Melatonin on Tau Hyperphosphorylation in Hypothermic SH-SY5Y Cells
CSEF · 2011
Effect of Three SIRT-1 Inducers on the Production of Alzheimer's Causing Beta Amyloid Plaques
CSEF · 2019
The Road to the Cure of Alzheimer's
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects